中国抗菌药物耐药时代的感染控制:进展、挑战与机遇
耐碳青霉烯鲍曼不动杆菌(CRAB)和耐碳青霉烯肺炎克雷伯菌(CRKP)等某些多重耐药菌(MDRO)发病率上升,相关感染主要为中国医院获得性;耐碳青霉烯铜绿假单胞菌相对稳定,而耐甲氧西林金黄色葡萄球菌和耐万古霉素屎肠球菌下降。CRAB和CRKP传播主要由优势高风险克隆谱系介导,分别为克隆复合群92和序列型11。
要点
- 中国感染控制法规与团队普及,但依从性常欠佳。
- CRAB和CRKP发病率上升,相关感染主要为医院获得性。
- CRAB和CRKP传播分别由克隆复合群92和序列型11主导。
核心结论
- 中国感染控制体系已建立但依从性欠佳,MDRO挑战带来反思与行动机遇。
研究设计与样本
- 综述中国1986年全国实施感染控制以来的进展、挑战与机遇。
主要发现
- CRAB和CRKP发病率上升,相关感染主要为中国医院获得性。
- 耐碳青霉烯铜绿假单胞菌相对稳定,MRSA和耐万古霉素屎肠球菌下降。
- CRAB和CRKP传播主要由克隆复合群92和序列型11介导。
临床怎么用
- 应重视感染控制依从性,并针对高风险克隆谱系开展防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 3 decades have passed since infection control was implemented nationwide in China in 1986. A comprehensive set of regulations and guidelines has been developed, and almost all hospitals have established infection control teams. However, compliance is variable and is usually suboptimal. The incidence of certain multidrug-resistant organisms (MDROs), including carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Klebsiella pneumoniae (CRKP), is increasing, and associated infections are mainly hospital-acquired in China. Carbapenem-resistant Pseudomonas aeruginosa has remained relatively stable, whereas methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterobacter faecium have been decreasing. The spread of CRAB and CRKP in China is largely mediated by dominant high-risk lineages, namely, clonal complex 92 for CRAB and sequence type 11 for CRKP. However, challenges owing to MDROs bring opportunities for rethinking, taking coordinated action, building capacity, changing behavior, and performing studies that reflect everyday situations in the Chinese healthcare system.
引用
- Zong Z, Wu A, Hu B, et al. Infection Control in the Era of Antimicrobial Resistance in China: Progress, Challenges, and Opportunities. Clin Infect Dis. 2020. PMID: 33367579. doi:10.1093/cid/ciaa1514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。